Teladoc Health (TDOC) Scheduled to Post Earnings on Thursday

Teladoc Health (NYSE:TDOC) is set to post its quarterly earnings results after the market closes on Thursday, November 1st. Analysts expect Teladoc Health to post earnings of ($0.36) per share for the quarter.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings data on Wednesday, August 1st. The health services provider reported ($0.37) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.38) by $0.01. Teladoc Health had a negative return on equity of 19.10% and a negative net margin of 37.78%. The company had revenue of $94.60 million during the quarter, compared to analysts’ expectations of $91.56 million. During the same quarter in the previous year, the business earned ($0.28) earnings per share. The firm’s revenue for the quarter was up 112.1% on a year-over-year basis. On average, analysts expect Teladoc Health to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Shares of NYSE TDOC opened at $63.22 on Tuesday. The company has a debt-to-equity ratio of 0.58, a current ratio of 3.14 and a quick ratio of 3.14. Teladoc Health has a twelve month low of $27.30 and a twelve month high of $89.05. The company has a market capitalization of $4.35 billion, a price-to-earnings ratio of -38.32 and a beta of 0.57.

In related news, VP Mark Hirschhorn sold 35,000 shares of the company’s stock in a transaction on Tuesday, September 25th. The stock was sold at an average price of $80.42, for a total transaction of $2,814,700.00. Following the transaction, the vice president now owns 10,000 shares of the company’s stock, valued at $804,200. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Jason N. Gorevic sold 25,000 shares of the company’s stock in a transaction on Thursday, August 16th. The stock was sold at an average price of $71.66, for a total value of $1,791,500.00. Following the transaction, the chief executive officer now directly owns 561,184 shares in the company, valued at approximately $40,214,445.44. The disclosure for this sale can be found here. Insiders have sold 156,706 shares of company stock worth $11,710,929 in the last ninety days. 3.95% of the stock is currently owned by corporate insiders.

TDOC has been the subject of several analyst reports. Oppenheimer upped their price target on Teladoc Health from $59.00 to $68.00 and gave the stock an “outperform” rating in a research note on Thursday, August 2nd. Canaccord Genuity restated a “buy” rating and set a $70.00 price target on shares of Teladoc Health in a research note on Thursday, August 2nd. Robert W. Baird upped their price target on Teladoc Health from $50.00 to $65.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 25th. Craig Hallum upped their price target on Teladoc Health from $70.00 to $80.00 and gave the stock a “buy” rating in a research note on Monday, October 15th. Finally, Citigroup upped their price target on Teladoc Health to $80.00 and gave the stock a “buy” rating in a research note on Thursday, July 19th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the company. Teladoc Health currently has an average rating of “Buy” and a consensus price target of $81.95.

Teladoc Health Company Profile

Teladoc Health, Inc provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Recommended Story: Bear Market – How and Why They Occur

Earnings History for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply